Market Tracker

11/21 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.43
Data as of Nov 21
 +0.02 / +1.42%
Today’s Change
1.24
Today|||52-Week Range
3.18
+2.88%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.41
Today’s open1.43
Day’s range1.41 - 1.45
Volume541,229
Average volume (3 months)1,027,371
Market cap$256.7M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-37.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...+0.10+0.68%
GALEGalena Biopharma Inc+0.21+11.29%
ECYTEndocyte Inc+0.04+0.62%
ALIMAlimera Sciences Inc-0.06-1.10%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateDecember 11, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts